The global biomarkers market Growth Accelerated by Increased Diagnostic Applications
Biomarkers are indicators that help to detect specific diseases or medical conditions such as cancer, heart disease and neurological disorders. Biomarkers act as strong diagnostic tools by detecting a biological state before actual clinical signs appear in the patient. Their ability to detect diseases at an early stage increases patients' chances of full recovery and cure.
The
global biomarkers market is estimated to be valued at US$ 17.97 Mn in 2023 and
is expected to exhibit a CAGR of 8.2%
over the forecast period 2023 to 2030, as highlighted in a new report published
by Coherent Market Insights.
Market key trends:
The increased usage of biomarkers in disease diagnosis has been a key trend
driving the growth of this market. Biomarkers help clinicians detect diseases
like cancer at an early stage when the chances of full recovery are higher. For
example, Cancer Antigen-125 (CA-125) is used to detect ovarian cancer,
prostate-specific antigen (PSA) for prostate cancer and carcinoembryonic
antigen (CEA) for colorectal, breast and lung cancers. Early detection allows
doctors to design and start treatment promptly, helping improve clinical
outcomes. Researchers are also working on identifying new biomarkers that can
detect diseases even before structural changes in organs occur. This will allow
predicting individuals at high risk of developing diseases and help prevent
illnesses, thereby further accelerating the demand for biomarkers.
Segment Analysis
The global
biomarkers market size is dominated by protein biomarkers sub segment
that accounts for more than 45% share of the total market. Protein biomarkers
are extensively employed in various disease diagnosis, staging, prognosis, and
personalized medicine for the treatment of diseases such as cancer,
neurological disorders, and cardiac disorders. The segment is expected to
retain its dominance over the forecast period owing to the increasing adoption
of protein biomarkers for various diagnostic applications and rising usage of
personalized medicine approach for tailored therapeutics.
Key Takeaways
The global biomarkers market is expected to witness high growth. The global
biomarkers market is estimated to be valued at US$ 17.97 Mn in 2023 and is
expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030.
Regional
analysis related content comprises North America currently holds the largest
share in the global biomarkers market owing to rising prevalence of chronic
diseases, increasing healthcare expenditure, and presence of advanced
healthcare facilities in the region. The Asia Pacific region is expected to be
the fastest growing market for biomarkers during the forecast period attributed
to rising geriatric population, increasing prevalence of chronic and lifestyle
diseases, growing healthcare expenditure, and improving healthcare
infrastructure in emerging economies.
Key players related content comprises Key players operating in the biomakers
market are Steris PLC, West Pharmaceutical Services Inc., Boston Analytical,
Intertek Pharmaceutical Services, Pace Analytical Services, Labcorp (Toxikon
Inc.), SGS SA, Eurofins Scientific, and Laboratory Testing Inc., among others.
Get
more insights on this topic: https://www.newsstatix.com/biomarkers-market-share-and-opportunity-analysis/
Explore
more information, Please visit: https://wotpost.com/optical-transceivers-enabling-high-speed-data-transmission/
Comments
Post a Comment